Center for Congenital Heart Disease, Providence Sacred Heart Children's Hospital, Spokane, WA, USA.
The Heart Center, Akron Children's Hospital, Akron, OH, USA.
Cardiol Young. 2021 Dec;31(12):1923-1928. doi: 10.1017/S1047951121001086. Epub 2021 Mar 26.
Catheter ablation is a safe and effective therapy for the treatment of supraventricular tachycardia in children. Current improvements in technology have allowed progressive reduction in radiation exposure associated with the procedure. To assess the impact of three-dimensional mapping, we compared acute procedural results collected from the Catheter Ablation with Reduction or Elimination of Fluoroscopy registry to published results from the Prospective Assessment after Pediatric Cardiac Ablation study.
Inclusion and exclusion criteria from the Prospective Assessment after Pediatric Cardiac Ablation study were used as guidelines to select patient data from the Catheter Ablation with Reduction or Elimination of Fluoroscopy registry to compare acute procedural outcomes between cohorts. Outcomes assessed include procedural and fluoroscopy exposure times, success rates of procedure, and complications.
In 786 ablation procedures, targeting 498 accessory pathways and 288 atrioventricular nodal reentrant tachycardia substrates, average procedural time (156.5 versus 206.7 minutes, p < 0.01), and fluoroscopy time (1.2 versus 38.3 minutes, p < 0.01) were significantly shorter in the study group. Success rates for the various substrates were similar except for manifest accessory pathways which had a significantly higher success rate in the study group (96.4% versus 93.0%, p < 0.01). Major complication rates were significantly lower in the study group (0.3% versus 1.6%, p < 0.01).
In a large, multicentre study, three-dimensional systems show favourable improvements in clinical outcomes in children undergoing catheter ablation of supraventricular tachycardia compared to the traditional fluoroscopic approach. Further improvements are anticipated as technology advances.
导管消融术是治疗儿童室上性心动过速的一种安全有效的治疗方法。目前技术的进步使得与该手术相关的辐射暴露逐渐减少。为了评估三维标测的影响,我们将导管消融术减少或消除透视注册研究中收集的急性手术结果与儿科心脏消融后前瞻性评估研究中的已发表结果进行了比较。
使用儿科心脏消融后前瞻性评估研究的纳入和排除标准作为指南,从导管消融术减少或消除透视注册研究中选择患者数据,以比较两组间的急性手术结果。评估的结果包括手术和透视暴露时间、手术成功率和并发症。
在 786 例消融手术中,靶向 498 条附加途径和 288 条房室结折返性心动过速基质,研究组的平均手术时间(156.5 分钟对 206.7 分钟,p<0.01)和透视时间(1.2 分钟对 38.3 分钟,p<0.01)明显缩短。各种基质的成功率相似,但显性附加途径的成功率明显更高(96.4%对 93.0%,p<0.01)。研究组的主要并发症发生率明显较低(0.3%对 1.6%,p<0.01)。
在一项大型多中心研究中,与传统透视方法相比,三维系统在儿童接受室上性心动过速导管消融术时显示出有利的临床结果改善。随着技术的进步,预计会有进一步的改进。